Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03642132
Title Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
Recruitment Completed
Gender female
Phase Phase III
Variant Requirements No
Sponsors Pfizer

peritoneum cancer

fallopian tube cancer

ovary epithelial cancer


Bevacizumab + Carboplatin + Paclitaxel

Carboplatin + Paclitaxel + Talazoparib

Avelumab + Carboplatin + Paclitaxel + Talazoparib

Age Groups: senior | adult
Covered Countries USA | ITA | BEL

No variant requirements are available.